Kurs
+0,18%
Kurs
+0,18%
Open
55,00
High
55,99
Low
52,00
Close
55,00
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
49,2 MNOK
Likviditet
49,2 MNOK
Rel. mcap
5,00%
Antal aktier
930 065
Likviditet under dagen för detta pressmeddelande
Kalender
| Tid* | ||
| 2025-02-26 | N/A | Bokslutskommuniké 2024 |
| 2024-11-27 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-21 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-21 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
| 2024-05-16 | - | Årsstämma |
| 2024-05-14 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-28 | - | Bokslutskommuniké 2023 |
| 2023-11-15 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-23 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-16 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-12 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
| 2023-05-11 | - | Årsstämma |
| 2023-02-28 | - | Bokslutskommuniké 2022 |
| 2022-11-23 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-24 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-16 | - | Kvartalsrapport 2022-Q1 |
| 2022-05-13 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
| 2022-05-12 | - | Årsstämma |
| 2022-03-31 | - | Bokslutskommuniké 2021 |
| 2021-12-22 | - | Extra Bolagsstämma 2021 |
| 2021-11-17 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-26 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-12 | - | Kvartalsrapport 2021-Q1 |
| 2021-05-06 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
| 2021-05-05 | - | Årsstämma |
| 2021-04-21 | - | Bokslutskommuniké 2020 |
| 2020-11-17 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-27 | - | Kvartalsrapport 2020-Q2 |
| 2020-07-07 | - | Split NYKD 1:5 |
| 2020-07-06 | - | Extra Bolagsstämma |
| 2020-05-12 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-22 | - | Extra Bolagsstämma |
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2020-10-22 08:05:11
Primary insider in Vaccibody AS Christian Åbyholm (board member) has through Caaby AS today purchased 270 000 shares in Vaccibody AS at a price of NOK 58 per share. After the transaction Christian Åbyholm through Caaby AS owns 1 974 720 shares. In addition Christian Åbyholm owns 100 000 warrants. Primary insider in Vaccibody AS Christian Åbyholm (board member) represents Andenaesgruppen. Andenaesgruppen has through Christiania Skibs AS today purchased 2 430 000 shares in Vaccibody AS at a price of NOK 58 per share. After the transaction Andenæsgruppen owns 17 680 000 shares. Primary insider in Vaccibody AS Christian Åbyholm (board member) represents Norda ASA. Norda ASA has today sold 2 700 000 shares in Vaccibody AS at a price of NOK 58 per share. After the transaction Norda ASA owns 7 996 755 shares.